WASHINGTON, DC – Andy Stergachis, PhD, BPharm, has been named Editor-in-Chief of the Journal of the American Pharmacists Association (JAPhA). In this position, Stergachis leads a team of Associate Editors in conducting peer review of manuscripts submitted for publication in the Science & Practice section of JAPhA and generally oversees the editorial content of the Journal.
“APhA members rely on JAPhA for information and updates that link the science of pharmacy with daily practice in health care settings of all types,” noted Thomas E. Menighan, BSPharm, MBA, ScD, APhA Executive Vice President and CEO. “We are pleased to gain Andy’s leadership and perspectives. He brings considerable publishing experience and professional knowledge to this position. We look forward to having him work with the team on enhancing JAPhA’s national and global reputation for scientific and professional excellence.”
At the University of Washington (UW) in Seattle, Stergachis is Professor of Epidemiology & Global Health, Adjunct Professor of Pharmacy and Health Services and Director of the Global Medicines Program in the School of Public Health. In the Global Medicines Program, Stergachis oversees a highly interdisciplinary team that seeks "to improve the use, safety, quality, risk-benefit profile, cost-effectiveness and affordability of medicines in resource-poor countries."
“Fifteen years ago when I published my first paper in JAPhA, I never imagined that one day I would have the privilege of serving as its Editor-in-Chief,” Stergachis said. “In 2012, the Journal marked 100 years since its founding. Today, I look forward to guiding JAPhA into its second century through a strategic-planning process that will seek input from the diverse community of authors and readers of this prestigious publication. I am passionate about strengthening the evidence base for pharmacy practice and for improved outcomes from medicines, and I plan to draw upon this leadership position to further that mission.”
Stergachis has been a driving force in the emergence of the disciplines of pharmacoepidemiology and pharmaceutical health outcomes research. Previously, he served as Chairman of the UW’s Department of Pharmacy and the Department of Pathobiology and Associate Dean of the School of Public Health. He also served as Vice President and Chief Pharmacist of drugstore.com. Stergachis is an author of more than 100 peer-reviewed publications in areas such as pharmacoepidemiology, pharmaceutical outcomes, pharmaceutical care and clinical epidemiology. He is one of a select group of pharmacists to be elected to membership in the Institute of Medicine, and is also a fellow in the International Society for Pharmacoepidemiology, Special Government Employee for the Food and Drug Administration, and member of Virtual Advisory Group to Global Alert and Response for the World Health Organization.
Stergachis has been honored with numerous awards for his accomplishments over the years, including 2009 Innovative Pharmacy Practice Award, Washington State Pharmacy Association; 2002 APhA Foundation Pinnacle Award, Career Achievement for Demonstrating Quality in the Medication-Use Process; 50 Most Influential Pharmacists in U.S. by American Druggist in 1999, and the 1990 Burroughs Wellcome–American College of Preventive Medicine Scholar in Pharmacoepidemiology. He earned his pharmacy degree from Washington State University and his MS and PhD from the University of Minnesota.
About the American Pharmacists Association
The American Pharmacists Association, founded in 1852 as the American Pharmaceutical Association, is a 501 (c)(6) organization, representing more than 62,000 practicing pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians and others interested in advancing the profession. APhA, dedicated to helping all pharmacists improve medication use and advance patient care, is the first-established and largest association of pharmacists in the United States. For more information, please visit www.pharmacist.com.
About the Journal of the American Pharmacists Association
JAPhA is the official peer-reviewed journal of the American Pharmacists Association (APhA). JAPhA is a forum for original research, reviews, experiences and opinion articles that link science to contemporary pharmacy practice to improve patient care. It provides information on pharmaceutical care, drug therapy, diseases and other health issues, trends in pharmacy practice and therapeutics, informed opinion and original research. For more information, please visit www.japha.org.